SSA
IMNM icon

Schonfeld Strategic Advisors’s Immunome IMNM Stock Holding History

Schonfeld Strategic Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.37M Buy
62,436
+30,337
+95% +$675K 0.01% 963
2025
Q4 		$689K Sell
32,099
-40,959
-56% -$719K ﹤0.01% 1268
2025
Q3 		$856K Buy
+73,058
New +$727K ﹤0.01% 1458
2023
Q4 		– Sell
-18,201
Closed -$152K – 2032
2023
Q3 		$152K Buy
+18,201
New +$134K ﹤0.01% 1457

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Schonfeld Strategic Advisors's IMNM Position: Q1 2026 in Review

Schonfeld Strategic Advisors increased its Immunome (IMNM) stake by 95% in Q1 2026, buying an estimated $675K and bringing the position to 62,436 shares worth $1.37M. The position accounts for 0.01% of the portfolio, ranked #963.

Schonfeld Strategic Advisors first reported a position in IMNM in Q3 2023 and has held it in 4 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Schonfeld Strategic Advisors held 62,436 shares of Immunome worth $1.37M as of Q1 2026.
  • Schonfeld Strategic Advisors bought 30,337 Immunome shares in Q1 2026, an estimated $675K.
  • Immunome made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #963 holding.
  • Schonfeld Strategic Advisors first reported a position in Immunome in Q3 2023 and has held it in 4 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.